Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.

Centene's stock plunges 40% with EPS slashed by 50%. Discover why valuation may seem cheap but key challenges make CNC stock a cautious investment.

Shares of Elevance Health Inc. tumbled toward a more than four-year low Thursday, after the health insurer slashed its full-year profit outlook and said pressures from rising Medicaid and Obamacare ...

Centene is also witnessing higher medical costs in its Medicaid business, particularly in areas of behavioral health, home health and high-cost drugs, and in certain areas, including New York and ...

The 18-year-old and first-round pick (19th overall) by St. Louis in the 2025 NHL Draft was certainly catching the eye of ...

Today, Benzinga's options scanner spotted 9 options trades for Centene. This isn't normal. The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish. Out of all of ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

Centene Corporation saw its share prices touch a new all-time low on Thursday as investors turned even more cautious ...

The market expects Centene (CNC) to deliver a year-over-year decline in earnings on higher revenues when it reports results ...

Centene CNC underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings ...

Analysts have provided mixed ratings on Centene’s stock. Cantor Fitzgerald reiterated an Overweight rating with a $90 price target, citing limited impact from tightened Medicaid work requirements.

Our Top 5 Analyst Questions Centene’s Q1 Earnings Call Josh Raskin (Nephron Research) asked about the nature and containment of flu-related costs.